Safety and convenience of once-weekly somapacitan in adult GH deficiency: a 26-week randomized, controlled trial

Is insulin-like growth factor-I a good marker for treatment adherence in growth hormone deficiency in adulthood?

(2016) Matthias K. Auer et al.   CLINICAL ENDOCRINOLOGY

The effect of growth hormone (GH) replacement on blood glucose homeostasis in adult nondiabetic patients with GH deficiency: real-life data from the NordiNet®International Outcome Study

(2016) Matthias M. Weber et al.   CLINICAL ENDOCRINOLOGY

Growth Hormone Research Society perspective on the development of long-acting growth hormone preparations: Table 1

(2016) Jens Sandahl Christiansen et al.   EUROPEAN JOURNAL OF ENDOCRINOLOGY

Reversible Albumin-Binding GH Possesses a Potential Once-Weekly Treatment Profile in Adult Growth Hormone Deficiency

(2016) Michael Højby Rasmussen et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

A Randomized Safety and Efficacy Study of Somavaratan (VRS-317), a Long-Acting rhGH, in Pediatric Growth Hormone Deficiency

(2016) Wayne V. Moore et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Growth hormone replacement in adults – current standards and new perspectives

(2015) Charlotte Höybye et al.   BEST PRACTICE & RESEARCH CLINICAL ENDOCRINOLOGY & METABOLISM

A discrete-choice experiment to quantify patient preferences for frequency of glucagon-like peptide-1 receptor agonist injections in the treatment of type 2 diabetes

(2015) A. Brett Hauber et al.   CURRENT MEDICAL RESEARCH AND OPINION

Reviewing the safety of GH replacement therapy in adults

(2015) Kirstine Stochholm et al.   GROWTH HORMONE & IGF RESEARCH

Reference Intervals for Insulin-like Growth Factor-1 (IGF-I) From Birth to Senescence: Results From a Multicenter Study Using a New Automated Chemiluminescence IGF-I Immunoassay Conforming to Recent International Recommendations

(2014) Martin Bidlingmaier et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

A Reversible Albumin-Binding Growth Hormone Derivative is Well Tolerated and Possesses a Potential Once-Weekly Treatment Profile

(2014) Michael Højby Rasmussen et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Compliance and Persistence in Pediatric and Adult Patients Receiving Growth Hormone Therapy

(2013) Ron Rosenfeld et al.   Endocrine Practice

24-Month Use of Once-Weekly GH, LB03002, in Prepubertal Children With GH Deficiency

(2013) Vaman Khadilkar et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Adult Growth Hormone Deficiency – Benefits, Side Effects, and Risks of Growth Hormone Replacement

(2013) Mary L. Reed et al.   Frontiers in Endocrinology

Favorable long-term effects of growth hormone replacement therapy on quality of life, bone metabolism, body composition and lipid levels in patients with adult-onset growth hormone deficiency

(2011) A.P. Jørgensen et al.   GROWTH HORMONE & IGF RESEARCH

Evaluation and Treatment of Adult Growth Hormone Deficiency: An Endocrine Society Clinical Practice Guideline

(2011) Mark E. Molitch et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Effects of Growth Hormone on Glucose, Lipid, and Protein Metabolism in Human Subjects

(2009) Niels Møller et al.   ENDOCRINE REVIEWS

Lipoatrophy in GH deficient patients treated with a long-acting pegylated GH

(2009) Philippe Touraine et al.   EUROPEAN JOURNAL OF ENDOCRINOLOGY

Validation of an abbreviated Treatment Satisfaction Questionnaire for Medication (TSQM-9) among patients on antihypertensive medications

(2009) Murtuza Bharmal et al.   Health and Quality of Life Outcomes